abciximab
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
**Off Market Drug**
        This medication is no longer available in the United States. Information provided here is for reference purposes only.      
Pronunciation: 
ab-six-i-mab
 To hear audio pronunciation of this topic, purchase a subscription or log in.
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- ReoPro
Ther. Class.
Pharm. Class.
glycoprotein iib iiia inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Abciximab." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51002/all/abciximab. 
Vallerand AHA, Sanoski CAC,  . Abciximab. Davis's Drug Guide. F.A. Davis Company; 2025. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51002/all/abciximab. Accessed October 26, 2025.
Vallerand, A. H., Sanoski, C. A., & ,  (2025). Abciximab. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51002/all/abciximab
Vallerand AHA, Sanoski CAC,  . Abciximab [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 October 26]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51002/all/abciximab.
* Article titles in AMA citation format should be in sentence-case
TY  -  ELEC
T1  -  abciximab
ID  -  51002
A1  -  Sanoski,Cynthia A,
AU  -  Vallerand,April Hazard,
AU  -  ,,
BT  -  Davis's Drug Guide
UR  -  https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/51002/all/abciximab
PB  -  F.A. Davis Company
ET  -  19
DB  -  Medicine Central
DP  -  Unbound Medicine
ER  -  

 Davis's Drug Guide
Davis's Drug Guide

